Crossmark

ASO Visual Abstract: Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Crossref DOI link: https://doi.org/10.1245/s10434-024-15740-9

Published Online: 2024-11-18

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Labora, Amanda

Shimizu, Takayuki

Moore, Alexandra

Premji, Alykhan

Armstrong, Wesley R.

Chen, Kevin Y.

Link, Jason

Chan, Charlotte S.

Allen-Aurbach, Martin S.

Donahue, Timothy R.
License Information

Text and Data Mining valid from 2024-11-18

Version of Record valid from 2024-11-18
More Information

Article History

First Online: 18 November 2024

DISCLOSURE

: Amanda Labora, Takayuki Shimizu, Alexandra Moore, Alykhan Premji, Wesley R. Armstrong, Daniel J. McClintick, Kevin Y. Chen, Martin S. Allen-Aurbach, and Timothy R. Donahue declare no conflicts of interest that may be relevant to the contents of this article.

Document is current

Any future updates will be listed below